Risky genes: Genetics, breast cancer and Jewish identity

Risky Genes: Genetics, breast cancer and Jewish identity

Volumn , Issue , 2012, Pages 1-164

  Mozersky, Jessica ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905154042     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203102572     Document Type: Book

References (192)

1. Abbott, A. (2005) 'Genetic patent singles out Jewish women', Nature, 436 (7047): 12.
2. Agar, N. (2004) Liberal Eugenics in Defence of Human Enhancement, Oxford: Wiley-Blackwell Publishing.
3. Angier, N. (1994) 'Vexing pursuit of breast cancer gene', New York Times, Science section, 12 July 1994.
4. Antoniou, A.C., Gayther, S.A., Stratton, J.F., Ponder, B.A. and Easton, D.F. (2000) 'Risk models for familial ovarian and breast cancer', Genetic Epidemiology, 18 (2): 173-90.
5. Antoniou, A.C., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D.M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjkoski, K., Kallioniemi, O.P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D.G. and Easton, D.F. (2003) 'Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies', American Journal of Human Genetics, 72 (5): 1117-30.
6. Arcos, B. (2002) 'Genetics of population isolates', Clinical Genetics, (61) 4: 233-247.
7. Arribas-Ayllon, M., Sarangi, S. and Clarke, A. (2008a) 'Managing self-responsibility through other-oriented blame: family accounts of genetic testing', Social Science & Medicine, 66 (7): 1521-1532.
8. Arribas-Ayllon, M., Sarangi, S. and Clarke, A. (2008b) 'The micropolitics of respon sibility vis-à-vis autonomy: parental accounts of childhood genetic testing and (non) disclosure', Sociology of Health & Illness, 30 (2): 255-271.
9. Azoulay, K.G. (2003) 'Not an innocent pursuit: the politics of a "jewish" genetic signature', Developing World Bioethics (3) 2: 119-126.
10. Azoulay, K.G. (2006) 'Reflections on "race" and the biologization of difference', Patterns of Prejudice, 40 (4-5): 353-379.
11. Balmaña, J., Domchek, S.M., Tutt, A. and Garber, J.E. (2011) 'Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers', Cancer Discovery, 1(1): 29.
12. Bamshad, M., Wooding, S., Salisbury, B.A. and Stephens, J.C. (2004) 'Deconstructing the relationship between genetics and race', Nature Review Genetics, 5 (8): 598-609.
13. Bankhead, C., Richards, S.H., Peters, T.J., Sharp, D.J., Hobbs, F.D.R., Brown, J., Roberts, L., Tydeman, C., Redman, V., Formby, J., Wilson, S. and Austoker, J. (2001) 'Improving attendance for breast screening among recent non-attenders: a randomised controlled trial of two interventions in primary care', Journal of Medical Screening, 8: 99-105.
14. Bankhead, C., Richards, S.H., Peters, T.J., Sharp, D.J., Hobbs, F.D.R., Brown, J., Roberts, L., Tydeman, C., Redman, V., Formby, J., Wilson, S. and Austoker, J. (1998) 'The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim', Human Molecular Genetics, 7 (5): 801-5.
15. Behar, D.M., Metspalu, E., Kivisild, T., Achilli, A., Hadid, Y., Tzur, S., Pereira, L., Amorim, A., Quintana-Murci, L., Majamaa, K., Herrnstadt, C., Howell, N., Balanovsky, O., Kutuev, I., Pshenichnov, A., Gurwitz, D., Bonne-Tamir, B., Torroni, A., Villems, R. and Skorecki, K. (2006) 'The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event', American Journal of Human Genetics, 78 (3): 487-97.
16. Berman, L.C. (2010) 'Blame, boundaries and birthrights', pp. 91-110 in S.A. Glenn and N.B. Sokoloff (eds) Boundaries of Jewish Identity, Seattle, WA: University of Washington Press.
17. Birenbaum Carmeli, D. (2004) 'Prevalence of Jews as subjects in genetic research: figures, explanation, and potential implications', American Journal of Medical Genetics, 130A: 76-83.
18. Bittles, A.H. (2005) 'Endogamy, consanguinity and community disease profiles', Public Health Genomics, 8 (1): 17-20.
19. Bradby, H. (1996) 'Genetics and racism', pp. 295-316 in T. Marteau and M. Richards (eds) The Troubled Helix: Social and Psychological Implications of the New Human Genetics, Cambridge: Cambridge University Press.
20. Bradby, H. (2007) 'Racial categories in medical practice: how useful are they?', PLoS Medicine, 4 (9): e271.
21. Breast Cancer Action (2011) Online, http://thinkbeforeyoupink.org/ (accessed 5 January 2012).
22. Broadstock, M., Michie, S. and Marteau, T. (2000) 'Psychological consequences of predictive genetic testing: A systematic review', European Journal of Human Genetics, 8 (10): 731-738.
23. Brodwin, P. (2002) 'Genetics, identity, and the anthropology of essentialism', Anthropological Quarterly, 75 (2): 323-330.
24. Brodwin, P. (2003) 'The importance of race and ethnic background in biomedical research and clinical practice', New England Journal of Medicine, 348 (12): 1077-92.
25. Byrne, B. (2004) 'Qualitative interviewing', pp. 179-192 in C. Seale (ed.) Researching Society and Culture, London: Sage.
26. Cancer Research UK (2008) 'Cancer stats incidence'. Online, http://info.cancerresearchuk.org/cancerstats/types/ovary/ (accessed 22 December 2011).
27. Casper, M. and Koenig, B. (1996) 'Reconfiguring nature and culture: intersections of medical anthropology and technoscience studies', Medical Anthropology Quarterly, 10 (4): 523-36.
28. Casper, M. and Koenig, B. (2009) 'Race and ancestry in biomedical research: Exploring the challenges', Genome Medicine, 1 (1): article 8.
29. Clow, B. (2001) 'Who's afraid of Susan Sontag? Or the myths and metaphors of cancer reconsidered', Social History of Medicine, 14 (2): 293-312.
30. Cochran, G., Hardy, J. and Harpending, H. (2005) 'Natural history of Ashkenazi intelligence', Journal of Biosocial Science, 38 (5): 659-93.
31. Collins, F. (2004) 'What we do and don't know about "race", "ethnicity", genetics and health at the dawn of the genome area', Nature Genetics, 36 (11): S13-S15, November supplement.
32. Connerton, P. (1989) How Societies Remember, Cambridge: Cambridge University Press.
33. Cowan, R.S. (2008) Heredity and Hope: The Case for Genetic Screening, Cambridge, MA: Harvard University Press.
34. Cox, S. and McKellin, W. (1999) 'There's this thing in our family: predictive testing and the construction of risk for Huntington's disease', pp. 121-148 in P. Conrad and J. Gabe (eds) Sociological Perspectives on the New Genetics, Oxford: Blackwell Publishing.
35. Croyle, R.T., Smith, K.R., Botkin, J.R., Baty, B. and Nash, J. (1997) 'Psychological responses to BRCA1 mutation testing: preliminary findings', Health Psychology, 16 (1): 63-72.
36. Croyle, R.T., Smith, K.R., Botkin, J.R., Baty, B. and Nash, J. (2008) 'Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome', Cancer Genetics and Cytogenetics, 184 (1): 62-6.
37. Dein, S. (2002) 'Mosiach is here now: just open your eyes and you can see him', Anthropology & Medicine, 9 (1): 25-36.
38. Dein, S. (2005) 'Ethnicity, genetics, and breast cancer: media portrayal of disease identities', Ethnicity & Health, 10 (3): 185-97.
39. Dorff, R.E.N. (1997) 'Jewish theological and moral reflections on genetic screening: the case of BRCA1', Health Matrix: Journal of Law-Medicine, 7: 65-96.
40. Durfy, S.J., Bowen, D.J., McTiernan, A., Sporleder, J. and Burke, W. (1999) 'Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington', Cancer Epidemiology, Biomarkers & Prevention, 8 (4): 369-75.
41. Duster, T. (1990) Backdoor to Eugenics, New York: Routledge.
42. Duster, T. (2005) 'Medicine enhanced: Race and reification in science', Science 307 (5712): 1050-1051.
43. Duster, T. (2006) 'The molecular reinscription of race: unanticipated issues in biotechnology and forensic science', Patterns of Prejudice, 40 (4-5): 427-41.
44. Edelson, P.J. (1997) 'The Tay Sachs disease screening program in the US as a model for the control of genetic disease: an historical overview', Health Matrix: Journal of Law-Medicine, 7: 125-33.
45. Edwards, J. and Strathern, M. (2000) 'Including our own', pp. 149-166 in J. Carsten (ed.) Cultures of Relatedness: New Approaches to the Study of Kinship, Cambridge: Cambridge University Press.
46. Ekstein, J. and Katzenstein, H. (2001) 'The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease', Advances in Genetics, 44: 297-310.
47. Ellison, G.T.H., Smart, A., Tutton, R., Outram, S.M., Ashcroft, R. and Martin, P. (2007) 'Racial categories in medicine: a failure of evidence-based practice?', PLoS Medicine, 4 (9): e287.
48. Endelman, T.M. (2004) 'Anglo-Jewish scientists and the science of race', Jewish Social Studies, 11 (1): 52-92.
49. Epstein, S. (2007) Inclusion: The Politics of Difference in Medical Research, Chicago, IL: University of Chicago Press.
50. Finkler, K. (2000) Experiencing the New Genetics: Family and Kinship on the Medical Frontier, Philadelphia: University of Pennsylvania Press.
51. Finkler, K. (2001) 'The kin in the gene - The medicalization of family and kinship in American society', Current Anthropology, 42 (2): 235-263.
52. Fletcher, R. (2007) 'Funding boost for cancer gene expert', Jewish Chronicle, 23 March 2007: 14.
53. Foster, M.W. and Sharp, R.R. (2002) 'Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity', Genome Research, 12 (6): 844-50.
54. Foucault, M. (1988) 'The ethic of care for the self as a practice of freedom, an interview with Michel Foucault on January 20, 1984', pp. 1-20 in J. Bernauer and D. Rasmussen (eds) The Final Foucault, Cambridge, MA: MIT Press.
55. Franklin, S. (1995) 'Science as culture, cultures of science', Annual Review of Anthropology, 24: 163-84.
56. Franklin, S. (2003) 'Re-thinking nature-culture', Anthropological Theory, 3 (1): 65-85.
57. Friedman, L. (2010) 'Intermarriage spurs Tay-Sachs advisory', Jewish Daily Forward. Online, http://www.forward.com/articles/129987/ (accessed 22 December 2011).
58. Fujimura, J.H. (1996) Crafting Science: A Sociohistory of the Quest for the Genetics of Cancer, Cambridge, MA: Harvard University Press.
59. Fujimura, J.H., Duster, T. and Rajagopalan, R. (2008) 'Introduction: race, genetics, and disease: questions of evidence, matters of consequence', Social Studies of Science, 38 (5): 643-56.
60. Fullwiley, D. (2007) 'Race and genetics: attempts to define the relationship', BioSocieties, 2 (2): 221-37.
61. Fullwiley, D. (2008) 'The biologistical construction of race: "admixture" technology and the new genetic medicine', Social Studies of Science, 38 (5): 695-735.
62. Galton, F. (1883) Inquiries into Human Faculty and Its Development, London: Dent & Co. Online, http://galton.org/ (accessed 9 January 2012).
63. Gessen, M. (2008) Blood Matters: A Journey along the Genetic Frontier, London: Granta Books.
64. Gibbon, S. and Novas, C. (eds) (2007) Biosocialities, Identity and the Social Sciences, London: Routledge.
65. Gilman, S.L. (1985) Difference and Pathology: Stereotypes of Sexuality, Race and Madness, Ithaca, NY: Cornell University Press.
66. Gilman, S.L. (2003) Jewish Frontiers: Essays on Bodies, Histories and Identities, New York: Palgrave Macmillan.
67. Gilman, S.L. (2006) 'Genetic diseases? Yes. But must we call them Jewish?', Jewish Daily Forward. Online, http://www.forward.com/articles/1471/ (accessed 13 January 2012).
68. Glenn, S.A. (2010) 'Funny, you don't look Jewish', pp. 64-91 in S.A. Glenn and N.B. Sokoloff (eds) Boundaries of Jewish Identity, Seattle, WA: University of Washington Press.
69. Glenn, S.A. and Sokoloff, N.B. (eds) (2010) Boundaries of Jewish Identity, Seattle, WA: University of Washington Press.
70. Goldstein, D.B. (2008) Jacob's Legacy: A Genetic View of Jewish History, New Haven, CT: Yale University Press.
71. Goodman, A.H., Heath, D. and Lindee, M.S. (eds) (2003) Genetic Nature/Culture: Anthropology and Science beyond the Two-Culture Divide, Berkeley, CA: University of California Press.
72. Goodman, M.J. and Goodman, L.E. (1982) 'The overselling of genetic anxiety', Hastings Center Report, 12 (5): 20-7.
73. Goodman, R.M. (1979) Genetic Disorders among the Jewish People, Baltimore, MD: Johns Hopkins University Press.
74. Gould, S.J. (1981) The Mismeasure of Man, New York: W.W. Norton & Company.
75. Graham, D. (2004) 'European Jewish identity at the dawn of the 21st century: A working paper. A report prepared for the American Jewish Joint Distribution Committee and Hanadiv Charitable Foundation'. Presented to the European General Assembly of the European Council of Jewish Communities, Budapest, 20-23 May 2004. Online, http://www.jpr.org.uk/sitemap.php (accessed 30 October 2011).
76. Grann, V.R., Whang, W., Jacobson, J.S., Heitjan, D.F., Antman, K.H. and Neugut, A.I. (1999) 'Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2', Journal of Clinical Oncology, 17 (2): 494.
77. Haber, D. (2002) 'Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations', New England Journal of Medicine, 346 (21): 1660-62.
78. Hallowell, N. (1999) 'Doing the right thing: genetic risk and responsibility', pp. 97-119 in P. Conrad and J. Gabe (eds) Sociological Perspectives on the New Genetics, Oxford: Blackwell Publishing.
79. Hallowell, N., Murton, F., Statham, H., Green, J.M. and Richards, M.P.M. (1997) 'Women's need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study', British Medical Journal, 314 (7076): 281.
80. Hallowell, N., Murton, F., Statham, H., Green, J.M. and Richards, M.P.M. (2006) 'Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family', Sociology of Health & Illness, 28 (7): 969-88.
81. Hamel, N., Feng, B.J., Foretova, L., Stoppa-Lyonnet, D., Narod, S.A., Imyanitov, E., Sinilnikova, O., Tihomirova, L., Lubinski, J., Gronwald, J., Gorski, B., Hansen, T., Nielsen, F.C., Thomassen, M., Yannoukakos, D., Konstantopoulou, I., Zajac, V., Ciernikova, S., Couch, F.J., Greenwood, C.M.T., Goldgar, D.E. and Foulkes, W.D. (2011) 'On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations', European Journal of Human Genetics, 19 (3): 300-6.
82. HapMap Project (2011) 'How Are Ethical Issues Being Addressed?' Online, http://snp.cshl.org/ethicalconcerns.html.en (accessed 13 January 2012).
83. Hashiloni-Dolev, Y. (2006) 'Between mothers, fetuses and society: reproductive genetics in the Israeli-Jewish context', Nashim: A Journal of Jewish Women's Studies & Gender Issues, 12 (1): 129-50.
84. JACOB (Jews against Cancer of the Breast) (2011) Online, http://www.jacobintl.org/ (accessed 22 December 2011).
85. Jasanoff, S. (ed.) (2004) States of Knowledge: The Co-production of Science and Social Order, London: Routledge.
86. Kaback, M.M. (2000) 'Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model', European Journal of Pediatrics, 159 (15): 192-5.
87. Kahn, S.M. (2000) Reproducing Jews: A Cultural Account of Assisted Conception in Israel, Durham, NC: Duke University Press.
88. Kahn, S.M. (2005) 'Are genes Jewish? Conceptual ambiguities in the new genetic age'. Paper presented at Jean and Samuel Center for Judaic Studies, University of Michigan, 16 March 2005.
89. Kenen, R. (1996) 'The at-risk health status and technology: a diagnostic invitation and the "gift" of knowing', Social Science and Medicine, 42 (22): 1545-53.
90. Kirsh, N. (2003) 'Population genetics in Israel in the 1950s', Isis, 94 (4): 631-55.
91. Kronn, D., Jansen, V. and Ostrer, H. (1998) 'Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the First 1000 cases at New York University Medical Center, New York, NY', Archives of Internal Medicine, 158 (7): 777-81.
92. Latour, B. and Woolgar, S. (1979) Laboratory Life: The Social Construction of Scientific Facts, London: Sage.
93. Lawton, J., Ahmard, N., Peel, E. and Hallowell, N. (2007) 'Contextualising accounts of illness: notions of responsibility and blame in white South Asian respondents' accounts of diabetes causation', Sociology of Health & Illness, 29 (6): 891-906.
94. Lehman, L.S., Weeks, J.C., Klar, N. and Garber, J. (2002) 'A population based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing', Genetics in Medicine, 4 (5): 346-52.
95. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S.J., Conway, T., Tonin, P., Lenoir, G. and Lynch, H. (1996) 'BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes', Journal of the American Medical Association, 275 (24): 1885-92.
96. Levene, S. (2005) 'Genetic screening in the Ashkenazi Jewish population - Is there a case for more testing?', Report for the National Screening Committee on the meeting held on 3 June 2004 at Guy's Hospital, London.
97. Levin, M. (2003) 'Ethical, cultural and religious aspects of hereditary cancer in Jewish communities', Cancer Therapy, 1: 269-73.
98. Levin, M. (1997) 'Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families', American Journal of Human Genetics, 60 (5): 1059-67.
99. Levy-Lahad, E., Gabai-Kapara, E., Kaufman, B., Catane, C., Regev, S., Renbaum, P., Beller, U., King, M.-C. and Lahad, A. (2011) 'Evidence for population-based screening of BRCA1 and BRCA' (program number 1191T). Presented at the 12th International Congress of Human Genetics/61st Annual Meeting of the American Society of Human Genetics, 13 October 2011, Montreal, Canada.
100. Lock, M. (1998) 'Breast cancer: reading the omens', Anthropology Today, 14 (4): 7-16.
101. Lodder, L.N., Frets, P.G., Trijsburg, R.W., Meijers-Heijboer, E.J., Klijn, J.G.M., Duivenvoorden, H.J., Tibben, A., Wagner, A., van der Meer, C.A., Devilee, P., Cornelisse, C.J. and Niermeijer, M.F. (1999) 'Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?', Journal of Medical Genetics, 36 (12): 906-13.
102. Lodder, L.N., Frets, P.G., Trijsburg, R.W., Meijers-Heijboer, E.J., Klijn, J.G.M., Duivenvoorden, H.J., Tibben, A., Wagner, A., van der Meer, C.A., Devilee, P., Cornelisse, C.J. and Niermeijer, M.F. (2001) 'Psychological impact of receiving a BRCA1/ BRCA2 test result', American Journal of Medical Genetics, 98 (1): 15-24.
103. London Jewish Cultural Centre (2007) 'Intermarriage - Was it ever a good thing?', course offered in May 2007.
104. Lowy, I. and Gaudilliere, J.P. (2008) 'Localizing the global: testing for hereditary risks of breast cancer', Science, Technology & Human Values, 33: 299-325.
105. Luna, F. (2009) 'Elucidating the concept of vulnerability: layers not labels', International Journal of Feminist Approaches to Bioethics, 2 (1): 121-39.
106. Lyall, S. (2009) 'Who is a Jew? Court ruling in Britain raises questions', New York Times, 8 September 2009. Online, http://www.nytimes.com/2009/11/08/world/europe/08britain.html?pagewanted=all (accessed 22 December 2011).
107. Lynch, H.T., Lemon, S.J. and Durham, C. (1997) 'A descriptive study of BRCA 1 testing and reactions to disclosure of test results', Cancer, 79: 2219-28.
108. Markel, H. (1997) 'Di Goldine Medina (the golden land): historical perspectives of eugenics and the East European (Ashkenazi) Jewish American community, 1880-1925', Health Matrix: Journal of Law-Medicine, 7 (1): 49-64.
109. Marks, J. (2002) 'Genes, bodies and species', pp. 14-28 in P. Peregrine and M. Ember (eds) Physical Anthropology: Original Readings in Method and Practice, Upper Saddle River, NJ: Prentice Hall.
110. Marks, J. (2008) 'Race: past, present and future', pp. 21-38 in B. Koenig, S.-J. Lee and S. Richardson (eds) Revisiting Race in a Genomic Age, New Brunswick, NJ: Rutgers University Press.
111. Marshall, G. (1993) 'Racial Classification: Popular and Scientific', pp. 116-127 in S. Harding (ed.) The 'Racial' Economy of Science, Bloomington, IN: Indiana University Press.
112. Martin, E. (1998) 'Anthropology and the cultural study of science', Science, Technology & Human Values, 23 (1): 24-44.
113. M'Charek, A. (2005) The Human Genome Diversity Project: An Ethnography of Scientific Practise, Cambridge: Cambridge University Press.
114. Metcalfe, K.A., Poll, A., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P. and Narod, S.A. (2009) 'Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women', Journal of Clinical Oncology, 28: 387-91.
115. Michael, M. and Birke, L. (1994) 'Accounting for animal experiments: identity and disreputable "others"', Science, Technology & Human Values, 19 (2): 189-204.
116. Michie, S., Bobrow, M. and Marteau, T.M. (2001) 'Predictive genetic testing in children and adults: a study of emotional impact', Journal of Medical Genetics, 38 (8): 519-26.
117. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, PA., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M. and Ding, W. (1994) 'A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1', Science, 266 (5182): 66-71.
118. Modell, B. and Darr, A. (2002) 'Genetic counselling and customary consanguineous marriage', Nature Review Genetics, 3 (3): 225-9.
119. Montoya, M.J. (2007) 'Bioethnic conscription: genes, race, and Mexicana/o ethnicity in diabetes research', Cultural Anthropology, 22 (1): 94-128.
120. Mor, P. and Oberle, K. (2008) 'Ethical issues related to BRCA gene testing in Orthodox Jewish women', Nursing Ethics, 15 (4): 512-22.
121. Motulsky, A.G. and Fraser, G.R. (1980) 'Effects of antenatal diagnosis and selective abortion on frequencies of genetic disorders', Clinics in Obstetrics and Gynaecology, 7 (1): 121-33.
122. Movement for Reform Judaism UK (2011) 'Abortion'. Online, http://www.reformjudaism.org.uk/a-to-z-of-reform-judaism/medical-ethics/abortion.html (accessed 22 December 2011).
123. Mozersky, J. and Joseph, G. (2010) 'Case studies in the co-production of populations and genetics: the making of "at risk" populations in BRCA genetics', Biosocieties, 5 (4): 415-39.
124. Murray, C. (2007) 'Jewish genius', Commentary Magazine. Online, http://www.commentarymagazine.com/article/jewish-genius/ (accessed 13 January 2012).
125. Narod, S. (2009) 'Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective', Salud Publica de Mexico, 51d (2): S191-6.
126. National Cancer Institute (1995) 'Scientists report new lead in the genetics of breast cancer', 28 September 1995. Online, http://archive.hhs.gov/news/press/1995pres/950928a.html (accessed 22 December 2011).
127. National Cancer Institute (2011) 'Genetics of breast and ovarian cancer physician data query'. Online, http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional (accessed 22 December 2011).
128. National Institute of Clinical Excellence (NICE) (2005) 'Familial breast cancer: Full guideline'. Online, http://guidance.nice.org.uk/CG41/Guidance/pdf/English (accessed 13 January 2012).
129. Nelson, A. (2008) 'Bio science: genetic genealogy testing and the pursuit of African ancestry', Social Studies of Science, 38 (5): 759-83.
130. Nelson, H.D., Huffman, L.H., Fu, R. and Harris, E.L. (2005) 'Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force', Annals of Internal Medicine, 43 (5): 362-79.
131. Neuhausen, S.L., Godwin, A.K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., Osorio, A., Stratton, M., Offit, K., Boyd, J., Caligo, M.A., Scott, R.J., Schofield, A., Teugels, E., Schwab, M., Cannon-Albright, L., Bishop, T., Easton, D., Benitez, J., King, M.C., Ponder, B.A.J., Weber, B., Devilee, P., Borg, Å., Narod, S.A. and Goldgar, D. (1998) 'Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study', American Journal of Human Genetics, 62 (6): 1381-8.
132. Neulander, J.S. (2006) 'Folk taxonomy, prejudice and the human genome: using disease as a Jewish ethnic marker', Patterns of Prejudice, 40: 381-98.
133. Novas, C. and Rose, N. (2000) 'Genetic risk and the birth of the somatic individual', Economy and Society, 29: 485-513.
134. Obasogie, O.K. (2009) 'Playing the gene card? A report on race and human biotechnology', Center for Genetics and Society. Online, http://www.geneticsandsociety.org/article.php?id=4465 (accessed 12 January 2012).
135. Oller, D.T. (1984) 'Jewish genetic diseases and Jewish illness behavior: a review of selected sociocultural literature', Jewish Social Studies, 46 (2): 177-87.
136. Olopade, O.F. (2004) 'Genetics in clinical cancer care: a promise unfulfilled among minority populations', Cancer Epidemiology, Biomarkers & Prevention, 13 (11): 1683-6.
137. Olopade, O.F., Williams, C.K. and Falkson, C.I. (eds) (2005) Breast Cancer in Women of African Descent, Netherlands: Springer.
138. Ossorio, P. and Duster, T. (2005) 'Race and genetics: controversies in biomedical, behavioural and forensic science', American Psychologist, 60 (1): 115-28.
139. Parthasarathy, S. (2007) Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care, Cambridge, MA: MIT Press.
140. Petersen, A. (2003) 'Governmentality, critical scholarship, and the medical humanities', Journal of Medical Humanities, 24 (3): 187-201.
141. Phillips, K.A., Warner, E., Meschino, W.S., Hunter, J., Abdolell, M., Glendon, G., Andrulis, I.L. and Goodwin, P.J. (2000) 'Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2', Clinical Genetics, 57 (5): 376-83.
142. Prainsack, B. (2006) '"Negotiating life"': the regulation of human cloning and embryonic stem cell research in Israel', Social Studies of Science, 36: 173-205.
143. Prainsack, B. (2007) 'Research populations: biobanks in Israel', New Genetics & Society, 26: 85-103.
144. Prainsack, B. and Firestine, O. (2006) 'Science for survival: biotechnology regulation in Israel', Science & Public Policy, 33: 33-46.
145. Prainsack, B. and Siegal, G. (2006) 'The rise of genetic couplehood? A comparative view of premarital genetic testing', Biosocieties, 1 (1): 17-36.
146. Press, N., Burke, W. and Durfy, S.J. (1997) 'How are Jewish women different from all other women? Anthropological perspectives on genetic susceptibility testing for breast cancer', Health Matrix: Journal of Law-Medicine, 7: 135-62.
147. Priest, L. (2008) 'Cancer test a genetic crystal ball for women', Globe and Mail, 24 May 2008. Online, http://www.theglobeandmail.com/life/cancer-test-a-genetic-crystal-ballfor-jewish-women/article687467/ (accessed 22 December 2011).
148. Proctor, R. (1999) The Nazi War on Cancer, Princeton, NJ: Princeton University Press.
149. Rabinovitch, D. (2007) Take off Your Party Dress: When Life's Too Busy for Breast Cancer, London: Simon & Schuster.
150. Rabinow, P. (1996) 'Artificiality and enlightenment: from sociobiology to biosociality', pp. 91-111 in P. Rabinow, Essays on the Anthropology of Reason, Princeton, NJ: Princeton University Press.
151. Rapp, R. (2000) Testing Women, Testing the Fetus, New York: Routledge.
152. Raz, A.E. (2010) Community Genetics and Genetic Alliances: Eugenics, Carrier Testing and Networks of Risk, Abingdon: Routledge.
153. Reardon, J. (2005) 'Race to the Finish' Identity and Governance in an Age of Genomics, Princeton, NJ: Princeton University Press.
154. Reardon, J. (2007) 'Democratic mis-haps: the problem of democratization in a time of biopolitics', Biosocieties, 2: 239-56.
155. Report of the Anglo-Israeli workshop on the genetic risk of breast cancer (2006), unpublished report of meeting held in Israel 22-6 April 2006.
156. Richards, M. (1996) 'Families, kinship and genetics', pp. 249-273 in T.M. Marteau and M. Richards (eds) The Troubled Helix: Social and Psychological Implications of the New Human Genetics, Cambridge: Cambridge University Press.
157. Risch, N., Burchard, E., Ziv, E. and Tang, H. (2002) 'Categorization of humans in biomedical research: genes, race and disease', Genome Biology, 3 (7): comment.
158. Risch, N., de Leon, D., Ozelius, L., Kramer, P., Almasy, L., Singer, B., Fahn, S., Breakefield, X. and Bressman, S. (1995) 'Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population', Nature Genetics, 9 (2): 152-9.
159. Risch, N., Tang, H., Katzenstein, H. and Ekstein, J. (2003) 'Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection', American Journal of Human Genetics, 72 (4): 812-22.
160. Robson, M.E., Storm, C.D., Weitzel, J., Wollins, D.S. and Offit, K. (2010) 'American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility', Journal of Clinical Oncology, 28 (5): 893-901.
161. Rose, N. (2007) Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century, Princeton, NJ: Princeton University Press.
162. Rosner, F. (2001) Biomedical Ethics and Jewish Law, Hoboken, NJ: KTAV Publishing House.
163. Rothenberg, K. (1997) 'Breast cancer, the genetic "quick fix" and the Jewish community', Health Matrix: Journal of Law-Medicine, 7 (1): 97-124.
164. Rothenberg, K. (2000) 'Report of the first community consultation on the responsible collection and use of samples for genetic research for the National Institute of General Medical Sciences', National Institute of the General Medical Sciences. Online, http://www.nigms.nih.gov/News/Reports/community_consultation.htm (accessed 22 December 2011).
165. Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C. and Lerman, C. (2002) 'Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample', Journal of Clinical Oncology, 20 (2): 514-20.
166. Seale, C. (2004) Researching Society and Culture, London: Sage.
167. Sharsheret: Your Jewish Community Facing Breast Cancer (2011). Online, http://www.sharsheret.org/ (accessed 22 December 2011).
168. Shkedi-Rafid, S. (2012) 'Screening for susceptibility genes: the point of view of asymptomatic carriers with no family history of the tested condition; and attitudes of health-care providers toward population screening', unpublished PhD thesis. To be submitted to the Hebrew University of Jerusalem.
169. Skinner, D. (2007) 'Groundhog day? The strange case of sociology, race and "science"', Sociology, 41 (5): 931-43.
170. Slatkin, M. (2004) 'A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases', American Journal of Human Genetics, 75: 282-93.
171. Sontag, S. (1990) Illness as Metaphor; and AIDS and Its Metaphor, New York: Random House.
172. Stolberg, S.G. (1998) 'Concern among Jews is heightened as scientists deepen genetic studies', New York Times, 22 April 1998.
173. Stone, L., Lurquin, P.F. and Cavalli-Sforza, L.L. (2007) Genes, Culture and Human Evolution: A Synthesis, Oxford: Blackwell Publishing.
174. Strathern, M. (1992) Reproducing the Future: Anthropology, Kinship and the New Reproductive Technologies, New York: Routledge.
175. Struewing, J.P., Hartge, P., Wacholder, S., Baker, S.M., Berlin, M., McAdams, M., Timmerman, M.M., Brody, L.C. and Tucker, M.A. (1997) 'The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews', New England Journal of Medicine, 336 (20): 1401-8.
176. Symons, L. (2006) 'Cancer breakthrough', Jewish Chronicle, 5 May 2006: 2.
177. Taussig, K.S., Rapp, R. and Heath, D. (2003) 'Flexible eugenics: technologies of the self in the age of genetics', pp. 58-76 in A.H. Goodman, D. Heath and M.S. Lindee (eds) Genetic Nature/Culture: Anthropology and Science beyond the Two-Culture Divide, Berkeley, CA: University of California Press.
178. Tate, S.K. and Goldstein, D.B. (2004) 'Will tomorrow's medicines work for everyone?', Nature Genetics, 36: S34-S42.
179. Thomas, M.G., Parfitt, T., Weiss, D.A., Skorecki, K., Wilson, J.F., le Roux, M., Bradman, N. and Goldstein, D.B.Y (2000) 'Chromosomes traveling south: the Cohen modal haplotype and the origins of the Lemba, the black Jews of Southern Africa', American Journal of Human Genetics, 66 (2): 674-86.
180. United Nations Educational, Scientific and Cultural Organisation (UNESCO) (1950) 'The race question'. Online, http://unesdoc.unesco.org/images/0012/001282/128291eo.pdf (accessed 22 December 2011).
181. United Synagogue of Conservative Judaism (1999) 'Genetic testing, discrimination and the Jewish community 1999 resolution by the United Synagogue'. Online, http://uscj2004.aptinet.com/Genetic_Testing_Disc6690.html (accessed 22 December 2011).
182. Wailoo, K. and Pemberton, S. (2006) The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay Sachs, Cystic Fibrosis and Sickle Cell Disease, Baltimore, MD: Johns Hopkins University Press.
183. Watson, M., Foster, C., Eeles, R., Eccles, D., Ashley, S., Davidson, R., Mackay, J., Morrison, P.J., Hopwood, P. and Evans, D.G.R. (2004) 'Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort', British Journal of Cancer, 91 (10): 1787-94.
184. Watson, M., Lloyd, S.M. and Eeles, R. (1996) 'Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting', Psycho-Oncology, 5: 233-9.
185. Weiler, J.H.H. (2010) 'Discrimination and identity in London', Jewish Review of Books, No. 1, Spring 2010. Online, http://www.jewishreviewofbooks.com/publications/detail/discrimination-and-identity-in-london-the-jewish-free-school-case (accessed 22 December 2011).
186. Weitzel, J.N., Lagos, V.I., Blazer, K.R., Nelson, R., Ricker, C., Herzog, J., McGuire, C. and Neuhausen, S. (2005) 'Prevalence of BRCA mutations and founder effect in high-risk Hispanic families', Cancer Epidemiology, Biomarkers & Prevention, 14 (7): 1666-71.
187. Weitzel, J.N., Lagos, V.I., Herzog, J.S., Judkins, T., Hendrickson, B., Ho, J.S., Ricker, C.N., Lowstuter, K.J., Blazer, K.R., Tomlinson, G. and Scholl, T. (2007) 'Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families', Cancer Epidemiology, Biomarkers & Prevention, 16 (8): 1615-20.
188. White House (2000) 'President Clinton announces the completion of the first draft of the human genome', Office of the Press Secretary. Online, http://www.ornl.gov/sci/techresources/Human_Genome/project/clinton1.shtml (accessed 22 December 2011).
189. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C. and Micklem, G. (1995) 'Identification of the breast cancer susceptibility gene BRCA2', Nature, 378 (6559): 789-92.
190. Zavestoski, S., McCormick, S. and Brown, P. (2004) 'Gender, embodiment, and disease: environmental breast cancer activists' challenges to science, the biomedical model, and policy', Science as Culture, 13 (4): 563-86.
191. Zertal, I. (2000) 'From the People's Hall to the Wailing Wall: a study in memory, fear, and war', Representations, 69: 96-126.
192. Ziogas, D.E., Christos, S.K. and Roukos, D.H. (2011) 'Preventing familial breast and ovarian cancer: major research advances with little implication', Women's Health, 7 (2): 135-8.